Bosulif and Gastritis - a phase IV clinical study of FDA data

Summary:

Gastritis is reported as a side effect among people who take Bosulif (bosutinib), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Gabapentin, and have Chronic myeloid leukaemia.

The phase IV clinical study analyzes which people have Gastritis when taking Bosulif. It is created by eHealthMe based on reports of 9,386 people who have side effects when taking Bosulif from the FDA, and is updated regularly.

What is Bosulif?

Bosulif has active ingredients of bosutinib. eHealthMe is studying from 9,401 Bosulif users. Check the latest studies of Bosulif.

What is Gastritis?

Gastritis (inflammation of stomach) is found to be associated with 1,717 drugs and 1,918 conditions by eHealthMe. Check the latest studies of Gastritis.

On Aug, 11, 2026

9,386 people reported to have side effects when taking Bosulif.
Among them, 22 people (0.23%) have Gastritis.

Among these 22 people:

How long have people been on Bosulif when they have Gastritis? *

What is the gender of people who have Gastritis when taking Bosulif? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Gastritis when taking Bosulif? *

What are other drugs people take besides Bosulif? *

Zyloprim: 3 people, 13.64%
Prochlorperazine Edisylate: 3 people, 13.64%
Celecoxib: 3 people, 13.64%
Crestor: 3 people, 13.64%
Dicyclomine Hydrochloride: 3 people, 13.64%
Eliquis: 3 people, 13.64%
Erythrocin Stearate: 3 people, 13.64%
Famotidine: 3 people, 13.64%
Fluorouracil: 3 people, 13.64%
Gabapentin: 3 people, 13.64%

What are other side effects people have besides Gastritis? *

Diarrhea: 13 people, 59.09%
Anaemia (lack of blood): 7 people, 31.82%
Fatigue (feeling of tiredness): 6 people, 27.27%
Abdominal Discomfort: 5 people, 22.73%
Pneumonia: 5 people, 22.73%
Weakness: 5 people, 22.73%
Nausea (feeling of having an urge to vomit): 5 people, 22.73%
Respiratory Tract Infection: 5 people, 22.73%
Dehydration (dryness resulting from the removal of water): 4 people, 18.18%
Drug Intolerance (drug sensitivity): 4 people, 18.18%

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 19 people, 86.36%
Pain: 4 people, 18.18%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 13.64%
High Blood Pressure: 3 people, 13.64%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 13.64%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 13.64%
Blast Crisis In Myelogenous Leukaemia: 2 people, 9.09%
Stress And Anxiety: 1 person, 4.55%
Reflux Gastritis (a condition in which the lining of a person's stomach becomes inflamed as a result of exposure to bile): 1 person, 4.55%
Nausea (feeling of having an urge to vomit): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Bosulif and have Gastritis?

- Check whether Gastritis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bosulif:

Bosulif (9,401 reports)

Gastritis treatments and more:

Gastritis (55,650 reports)

Browse all side effects of Bosulif:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gastritis:

Gastritis (1,717 drugs)

Browse all the conditions that are associated with Gastritis:

Gastritis (1,918 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bosutinib (the active ingredients of Bosulif) and Bosulif (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.